Characterisation of chromatin modifiers in endometrial cancer

Characterisation of chromatin modifiers in endometrial cancer

<p>Chromatin organization is a critical regulator of gene expression and cell phenotype, and is frequently dysregulated in cancer. Endometrial cancer (EC) is the most common gynecological malignancy, and casues significant morbidity and mortality. EC is notable for recurrent alterations in chr...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Kedzierska, KZ
Awduron Eraill:	Church, D
Fformat:	Traethawd Ymchwil
Iaith:	English
Cyhoeddwyd:	2024
Pynciau:	Cancer

Eitemau Tebyg

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
gan: Dore M, et al.
Cyhoeddwyd: (2021-10-01)

Prognostic Significance of Dysregulated Epigenomic and Chromatin Modifiers in Cervical Cancer
gan: Aswathy Mary Paul, et al.
Cyhoeddwyd: (2021-10-01)

A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients
gan: Zesi Liu, et al.
Cyhoeddwyd: (2022-10-01)

Characterising ISWI chromatin remodeler in Trypanosoma cruzi
gan: Yirys Díaz-Olmos, et al.

Druggable genetic targets in endometrial cancer✰,✰✰
gan: Steven Lehrer, et al.
Cyhoeddwyd: (2022-01-01)

The treatment of special types of endometrial cancer
gan: Meng Zhang, et al.
Cyhoeddwyd: (2022-08-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
gan: An-Ju Chou, et al.
Cyhoeddwyd: (2024-11-01)

Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread
gan: Stephanie A. Sullivan, et al.
Cyhoeddwyd: (2021-05-01)

Importance of the endometrial immune environment in endometrial cancer and associated therapies
gan: Hannah van der Woude, et al.
Cyhoeddwyd: (2022-08-01)

How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
gan: Brigida Anna Maiorano, et al.
Cyhoeddwyd: (2022-04-01)

Chromatin structure in cancer
gan: Meng Wang, et al.
Cyhoeddwyd: (2022-07-01)

Robotics in Endometrial Cancer Care
gan: Joseph Ng
Cyhoeddwyd: (2013-11-01)

The modern management of endometrial cancer
gan: Catherine M. Holland, et al.
Cyhoeddwyd: (2011-12-01)

The modern management of endometrial cancer
gan: Catherine M. Holland, et al.
Cyhoeddwyd: (2011-12-01)

GENETIC ASPECTS OF ENDOMETRIAL CANCER
gan: V. A. Pushkarev, et al.
Cyhoeddwyd: (2014-09-01)

The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
gan: Sebastian Stępień, et al.
Cyhoeddwyd: (2023-04-01)

Racioethnic Disparities in Endometrial Cancer Outcomes
gan: Ojone Illah, et al.
Cyhoeddwyd: (2024-02-01)

TRENDS OF ENDOMETRIAL CANCER IN CENTRAL INDIA: AN INSTITUTIONAL REVIEWTrends of Endometrial Cancer in Central India: An Institutional Review
gan: Dhruv G Patel, et al.
Cyhoeddwyd: (2020-06-01)

Management of inoperable endometrial cancer
gan: Supakorn Pitakkarnkul, et al.
Cyhoeddwyd: (2022-07-01)

The Roles of Endoscopy in Endometrial Cancer
gan: Chyi-Long Lee, et al.
Cyhoeddwyd: (2008-12-01)

PREDICTION ENDOMETRIAL CANCER IN WOMEN WITH ENDOMETRIAL HYPERPLASTIC PROCESSES IN PREMENOPAUSAL
gan: A. L. Unanyan, et al.
Cyhoeddwyd: (2016-09-01)

The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer
gan: Jakub Dobroch, et al.
Cyhoeddwyd: (2022-03-01)

KLHL14, an ovarian and endometrial-specific gene, is over-expressed in ovarian and endometrial cancer
gan: Mi Han, et al.
Cyhoeddwyd: (2020-01-01)

Assessment of Preoperative Endometrial Histopathological Sampling as a Predictor of Final Surgical Pathology in Endometrial Cancer
gan: Mario Augusto Silveira Bueno Piotto, et al.

Telomeres and telomerase in endometrial cancer and hyperplasia
gan: Anna Pańczyszyn, et al.
Cyhoeddwyd: (2024-03-01)

Epidemiology of Endometrial Cancer in North of Iran
gan: Shahla Yazdani, et al.
Cyhoeddwyd: (2017-01-01)

The significance of markers in the diagnosis of endometrial cancer
gan: Monika M. Żyła, et al.
Cyhoeddwyd: (2016-11-01)

Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
gan: Amritha Sreekumar, et al.
Cyhoeddwyd: (2023-01-01)

Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses
gan: Song YJ, et al.
Cyhoeddwyd: (2023-10-01)

Accuracy of Pre-operative Endometrial Sampling for the Detection of High Grade Endometrial Cancer
gan: Uraiwan Khomphaiboonkij, et al.
Cyhoeddwyd: (2015-09-01)

Telomerase and Telomeres in Endometrial Cancer
gan: Rafah A. A. Alnafakh, et al.
Cyhoeddwyd: (2019-05-01)

Comparison of Oncological and Surgical Outcomes of Robot-Assisted, Laparoscopic Modified Radical Hysterectomy and Laparotomy for Endometrial Cancer
gan: Masako Ishikawa, et al.
Cyhoeddwyd: (2024-02-01)

Chromatin and the DNA damage response: The cancer connection
gan: Martijn S. Luijsterburg, et al.
Cyhoeddwyd: (2011-08-01)

Psychometric validation of the Functional Assessment of Cancer Therapy‐Endometrial among endometrial cancer patients
gan: Sooyeon Kim, et al.
Cyhoeddwyd: (2024-03-01)

Model Predicting the Risk of Endometrial Hyperplasia Developing into Endometrial Cancer
gan: Su J, et al.
Cyhoeddwyd: (2024-09-01)

SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER
gan: A. I. Berishvili, et al.
Cyhoeddwyd: (2017-06-01)

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
gan: Haley A. Moss, et al.
Cyhoeddwyd: (2014-12-01)

Axin2+ endometrial stem cells: the source of endometrial regeneration and cancer
gan: Shafiq M. Syed, et al.
Cyhoeddwyd: (2020-05-01)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
gan: Dan Kuai, et al.
Cyhoeddwyd: (2023-07-01)

A multiomics comparison between endometrial cancer and serous ovarian cancer
gan: Hui Zhong, et al.
Cyhoeddwyd: (2020-01-01)